BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28882595)

  • 1. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
    Wang Y; Zhou J; Wang Z; Wang P; Li S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Positive Feedback Loop of lncRNA-
    Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
    Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
    [No Abstract]   [Full Text] [Related]  

  • 5. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2.
    Zou MF; Ling J; Wu QY; Zhang CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7183-7188. PubMed ID: 30468460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer.
    Chang Z; Cui J; Song Y
    Gene; 2018 May; 654():36-42. PubMed ID: 29452232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA PVT1 promotes epithelial‑mesenchymal transition via the TGF‑β/Smad pathway in pancreatic cancer cells.
    Zhang X; Feng W; Zhang J; Ge L; Zhang Y; Jiang X; Peng W; Wang D; Gong A; Xu M
    Oncol Rep; 2018 Aug; 40(2):1093-1102. PubMed ID: 29845201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
    Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
    Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
    Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
    Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
    Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer.
    Li X; Chen W; Wang H; Wei Q; Ding X; Li W
    Oncol Rep; 2017 Jul; 38(1):465-471. PubMed ID: 28534994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
    Li H; Chen S; Liu J; Guo X; Xiang X; Dong T; Ran P; Li Q; Zhu B; Zhang X; Wang D; Xiao C; Zheng S
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2350-2355. PubMed ID: 29277611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
    Zhang S; Zhang G; Liu J
    APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription.
    Zhuang W; Ge X; Yang S; Huang M; Zhuang W; Chen P; Zhang X; Fu J; Qu J; Li B
    Stem Cells; 2015 Jun; 33(6):1985-97. PubMed ID: 25753650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis.
    Keshavarz M; Asadi MH
    FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.